Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Metabolic equivalents fail to indicate metabolic load in post-myocardial infarction patients during the modified Bruce treadmill walking test.

Woolf-May K, Meadows S, Ferrett D, Kearney E.

BMJ Open Sport Exerc Med. 2017 Mar 17;2(1):e000173. doi: 10.1136/bmjsem-2016-000173. eCollection 2016.

2.

Game-Based Augmented Visual Feedback for Enlarging Speech Movements in Parkinson's Disease.

Yunusova Y, Kearney E, Kulkarni M, Haworth B, Baljko M, Faloutsos P.

J Speech Lang Hear Res. 2017 Jun 22;60(6S):1818-1825. doi: 10.1044/2017_JSLHR-S-16-0233.

PMID:
28655041
3.

Evaluation of skin firmness by the DynaSKIN, a novel non-contact compression device, and its use in revealing the efficacy of a skincare regimen featuring a novel anti-ageing ingredient, acetyl aspartic acid.

Kearney EM, Messaraa C, Grennan G, Koeller G, Mavon A, Merinville E.

Skin Res Technol. 2017 May;23(2):155-168. doi: 10.1111/srt.12314. Epub 2016 Aug 21.

PMID:
27546316
4.

History repeats itself: the family medication history and pharmacogenomics.

Smith TR, Kearney E, Hulick PJ, Kisor DF.

Pharmacogenomics. 2016 May;17(7):669-78. doi: 10.2217/pgs-2015-0015. Epub 2016 May 4.

PMID:
27143300
5.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

6.

Automated immunoassays for 25-hydroxyvitamin D (25-OHD): do plasticisers interfere?

Carter GD, Jones J, Ketheeswaran M, Shannon J, Singh B, Kearney E, Berry JL.

J Steroid Biochem Mol Biol. 2015 Apr;148:38-40. doi: 10.1016/j.jsbmb.2014.11.008. Epub 2014 Nov 13. Review.

PMID:
25448742
7.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

8.

Tongue-palate contact during selected vowels in children with speech sound disorders.

Lee A, Gibbon FE, Kearney E, Murphy D.

Int J Speech Lang Pathol. 2014 Dec;16(6):562-70. doi: 10.3109/17549507.2013.862857. Epub 2013 Dec 18.

PMID:
24345004
9.

Pillars article: visualization of Peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1994. 1: 327-339.

Kearney ER, Pape KA, Loh DY, Jenkins MK.

J Immunol. 2013 Dec 1;191(11):5327-39. No abstract available.

11.

Motor speech treatment protocol for developmental motor speech disorders.

Namasivayam A, Pukonen M, Hard J, Jahnke R, Kearney E, Kroll R, van Lieshout P.

Dev Neurorehabil. 2015;18(5):296-303. doi: 10.3109/17518423.2013.832431. Epub 2013 Oct 2.

PMID:
24088085
12.

Internal quality control.

Kearney E.

Methods Mol Biol. 2013;1065:277-89. doi: 10.1007/978-1-62703-616-0_18.

PMID:
23996371
13.

Structured care of diabetes in general practice: a qualitative study of the barriers and facilitators.

O'Connor R, Mannix M, Mullen J, Powys L, Mannion M, Nolan HA, Kearney E, Cullen W, Griffin M, Saunders J.

Ir Med J. 2013 Mar;106(3):77-80.

PMID:
23951976
14.

Apparent improvement in survival for carcinoma of the cervix following the introduction of chemoradiation--a Will Rogers phenomenon.

Foley ME, Ryan H, Kearney E, Herlihy A, Craig H, Kelehan P, Mooney E, Lenehan P, Flannelly G.

Ir Med J. 2013 Mar;106(3):74-7.

PMID:
23951975
15.

Evidence-based use of serum protein electrophoresis in laboratory medicine.

McTaggart MP, Kearney EM.

Clin Chem Lab Med. 2013 Jun;51(6):e113-5. doi: 10.1515/cclm-2012-0711. No abstract available.

PMID:
23241676
16.

Effect of Patent Blue V(®) dye on sample interference indices on the Abbott Architect.

McTaggart MP, Cannon LP, Kearney EM.

Ann Clin Biochem. 2012 Sep;49(Pt 5):510-1. doi: 10.1258/acb.2012.012044. Epub 2012 Aug 22. No abstract available.

PMID:
22914445
17.

Attenuation of the jasmonate burst, plant defensive traits, and resistance to specialist monarch caterpillars on shaded common milkweed (Asclepias syriaca).

Agrawal AA, Kearney EE, Hastings AP, Ramsey TE.

J Chem Ecol. 2012 Jul;38(7):893-901. doi: 10.1007/s10886-012-0145-3. Epub 2012 Jun 3.

PMID:
22661306
18.

Identification of a macro-alkaline phosphatase complex in a patient with inflammatory bowel disease.

McTaggart MP, Rawson C, Lawrence D, Raney BS, Jaundrill L, Miller LA, Murtinho-Braga J, Kearney EM.

Ann Clin Biochem. 2012 Jul;49(Pt 4):405-7. doi: 10.1258/acb.2011.011224. Epub 2012 Mar 27.

PMID:
22454544
19.

Fatness, fitness, and cardiometabolic risk factors in middle-aged white men.

O'Donovan G, Kearney E, Sherwood R, Hillsdon M.

Metabolism. 2012 Feb;61(2):213-20. doi: 10.1016/j.metabol.2011.06.009. Epub 2011 Aug 4.

PMID:
21820133
20.

An embryonic culture system for the investigation of striatal medium spiny neuron dendritic spine development and plasticity.

Penrod RD, Kourrich S, Kearney E, Thomas MJ, Lanier LM.

J Neurosci Methods. 2011 Aug 30;200(1):1-13. doi: 10.1016/j.jneumeth.2011.05.029. Epub 2011 Jun 13.

Supplemental Content

Loading ...
Support Center